Prostate Cancer | Prostate Cancer Hormone Therapy Associated With Heart Problems | Prostate cancer information
New research has found that hormone therapy used to treat men with advanced prostate cancer is associated with an increased chance of developing various heart problems.
The findings of the study, the largest and most comprehensive to date on the issue, indicate [...]
According to research published in the British Journal of Cancer, tiny bubbles of fat in urine hold molecules that could predict whether prostate cancer is aggressive.
Prostate cancer is the most common cancer in men in the UK, with around 34,000 new cases diagnosed each year. Around 10,000 men die from prostate cancer each year in [...]
Viralytics Limited (ASX: VLA) has received ethics committee approval to increase the dosage levels of CAVATAK™ in its Phase I intravenous breast cancer, prostate cancer and melanoma trial.
Dosing will now commence at what was the highest dosing level of the original trial schedule and escalate to approximately 100 fold higher levels than planned for in [...]
According to a study by John S. Witte and colleagues, omega-3 fatty acids appear protective against advanced prostate cancer, and this effect may be modified by a genetic variant in the COX-2 gene.
“Previous research has shown protection against prostate cancer, but this is one of the first studies to show protection against advanced prostate cancer [...]
Epidemiological studies have shown marked variations in prostate cancer incidence and mortality across different geographic regions, leading to the rising interest in the role of nutrition in prostate cancer risk.
There is sufficient evidence that a diverse diet, rich in vegetables, can reduce the risk of prostate cancer.
Researchers have now provided a review on prostate cancer [...]
Many people were hoping the long-awaited results of two major cancer prevention studies would deliver important news about stopping the spread of prostate cancer. But to the health community’s dismay, researchers delivered a “no effect” verdict in December 2008 when the data were published in the online edition of the Journal of the American Medical [...]
While cities have shown considerable racial disparities in cancer survival, those racial disparities virtually disappear among smaller populations, such as neighborhoods within that city. The finding comes from a new analysis published in the May 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study examined breast and prostate cancer [...]
A new drug with a radically different way of attacking prostate cancer has done well in an initial trial and is ready for larger-scale testing, researchers report.
One standard treatment for the malignancy is to inhibit the activity of androgens, male hormones such as testosterone that help drive tumor growth. Existing anti-androgens try to “shut down [...]
MedWire News: Prostate cancer is not predicted by inflammation on initial and subsequent biopsy, say US researchers who nevertheless caution that a role for inflammation in prostate cancer pathogenesis cannot be dismissed.
Previous epidemiologic studies have revealed correlations between prostate cancer and sexually transmitted infections, and antioxidant and anti-inflammatory drug intake. Nevertheless, the role of chronic [...]
 |  |  |  |  |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |  |  |  |  |
| By N2H | |||||||||||||